Our Executive Committee

Vasant (Vas) Narasimhan, M.D. (Photo)

Vasant (Vas) Narasimhan, M.D.

Chief Executive Officer

American

James (Jay) Bradner, M.D. (Photo)

James (Jay) Bradner, M.D.

President of the Novartis Institutes for BioMedical Research (NIBR)

American

Karen L. Hale (Photo)

Karen L. Hale

Chief Legal Officer

American

Harry Kirsch (Photo)

Harry Kirsch

Chief Financial Officer

German/Swiss

Robert (Rob) Kowalski (Photo)

Robert (Rob) Kowalski

Chief People & Organization Officer

American

Steffen Lang, Ph.D. (Photo)

Steffen Lang, Ph.D.

Global Head of Novartis Technical Operations (NTO)

German/Swiss

Klaus Moosmayer, Ph.D. (Photo)

Klaus Moosmayer, Ph.D.

Chief Ethics, Risk & Compliance Officer

German

Richard Saynor (Photo)

Richard Saynor

Chief Executive Officer of Sandoz

British

Susanne Schaffert, Ph.D. (Photo)

Susanne Schaffert, Ph.D.

President of Novartis Oncology

German

John Tsai, M.D. (Photo)

John Tsai, M.D.

Head of Global Drug Development and Chief Medical Officer

American

Marie-France Tschudin (Photo)

Marie-France Tschudin

President of Novartis Pharmaceuticals

Swiss

Robert Weltevreden (Photo)

Robert Weltevreden

Head of Novartis Business Services (NBS)

Dutch